Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3rgf | BAX | Cyclin-dependent kinase 8 | 2.7.11.22 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3rgf | BAX | Cyclin-dependent kinase 8 | 2.7.11.22 | 1.000 | |
| 2qe4 | JJ3 | Estrogen receptor | / | 0.494 | |
| 4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.487 | |
| 5jtb | ZMA | Adenosine receptor A2a | / | 0.486 | |
| 4qe6 | JN3 | Bile acid receptor | / | 0.484 | |
| 1iep | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.482 | |
| 1upw | 444 | Oxysterols receptor LXR-beta | / | 0.482 | |
| 4eyj | N61 | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.480 | |
| 3jyn | NDP | Quinone oxidoreductase | / | 0.477 | |
| 3vhk | BPK | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.475 | |
| 4fc0 | 0T2 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.472 | |
| 5k2d | ZMA | Adenosine receptor A2a | / | 0.472 | |
| 1cbr | REA | Cellular retinoic acid-binding protein 1 | / | 0.471 | |
| 3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.470 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.470 | |
| 4rvu | NDP | Probable quinone reductase Qor (NADPH:quinone reductase) (Zeta-crystallin homolog protein) | / | 0.469 | |
| 3cz7 | ACO | Histone acetyltransferase RTT109 | 2.3.1.48 | 0.468 | |
| 3oq1 | 3OQ | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.467 | |
| 3w1w | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.467 | |
| 3nx4 | NAP | Putative oxidoreductase | / | 0.466 | |
| 1ysx | 4EB | Serum albumin | / | 0.465 | |
| 3vnt | 0JA | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.465 | |
| 4a6d | SAM | Acetylserotonin O-methyltransferase | 2.1.1.4 | 0.465 | |
| 4j6c | STR | Cytochrome P450 monooxygenase | / | 0.465 | |
| 3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.464 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.464 | |
| 5k2b | ZMA | Adenosine receptor A2a | / | 0.464 | |
| 4uhr | NGI | Adenosine receptor A2a | / | 0.464 | |
| 1fel | FEN | Retinol-binding protein 4 | / | 0.463 | |
| 1iol | EST | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.463 | |
| 3efl | 706 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.463 | |
| 1n4u | FAE | Cholesterol oxidase | 1.1.3.6 | 0.461 | |
| 1wuu | ANP | Galactokinase | 2.7.1.6 | 0.460 | |
| 1xqc | AEJ | Estrogen receptor | / | 0.460 | |
| 1xu7 | CPS | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.460 | |
| 1ztq | 033 | Collagenase 3 | 3.4.24 | 0.460 | |
| 2aib | ERG | Beta-elicitin cinnamomin | / | 0.460 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.460 | |
| 4jvb | 1M0 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.459 | |
| 1sqv | UHD | Cytochrome b | / | 0.458 | |
| 2ewp | TXF | Estrogen-related receptor gamma | / | 0.458 | |
| 2g78 | REA | Cellular retinoic acid-binding protein 2 | / | 0.458 | |
| 3a1l | 2CC | Cytochrome P450 | / | 0.458 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.458 | |
| 5doz | NDP | JamJ | / | 0.458 | |
| 1osv | CHC | Bile acid receptor | / | 0.457 | |
| 3hub | 469 | Mitogen-activated protein kinase 14 | / | 0.457 | |
| 3wv9 | FEG | Hmd co-occurring protein HcgE | / | 0.457 | |
| 4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.457 | |
| 5k2a | ZMA | Adenosine receptor A2a | / | 0.457 | |
| 1hrv | SDZ | Genome polyprotein | / | 0.456 | |
| 1ot7 | IU5 | Bile acid receptor | / | 0.456 | |
| 2ic3 | HBY | Gag-Pol polyprotein | 2.7.7.49 | 0.456 | |
| 2xc3 | RT8 | Steroid C26-monooxygenase | 1.14.13.141 | 0.456 | |
| 3td8 | D2R | Dihydrofolate reductase | 1.5.1.3 | 0.456 | |
| 3ua5 | 06X | Cytochrome P450 2B6 | 1.14.13 | 0.456 | |
| 3w8z | HTK | Putative FAD-dependent oxygenase EncM | / | 0.456 | |
| 4i2q | 1BT | Gag-Pol polyprotein | 2.7.7.49 | 0.456 | |
| 1hk1 | T44 | Serum albumin | / | 0.455 | |
| 2oiq | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 3ruk | AER | Steroid 17-alpha-hydroxylase/17,20 lyase | / | 0.455 | |
| 3zbn | COA | 3-ketoacyl-CoA thiolase-like protein | / | 0.455 | |
| 4jvf | 17X | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.455 | |
| 4rek | FAD | Cholesterol oxidase | 1.1.3.6 | 0.455 | |
| 4u2l | SFD | Cholesterol oxidase | 1.1.3.6 | 0.455 | |
| 5hi2 | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.455 | |
| 5iua | 6DX | Adenosine receptor A2a | / | 0.455 | |
| 1lwl | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.454 | |
| 2uvy | GVI | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.454 | |
| 3gcs | BAX | Mitogen-activated protein kinase 14 | / | 0.454 | |
| 3jsw | JAR | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.454 | |
| 4hia | FMN | LOV protein | / | 0.454 | |
| 3cxh | SMA | Cytochrome b | / | 0.453 | |
| 3dy8 | IBM | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.453 | |
| 3h1j | SMA | Cytochrome b | / | 0.453 | |
| 3u2l | FAD | FAD-linked sulfhydryl oxidase ALR | 1.8.3.2 | 0.453 | |
| 4l98 | LRG | Peroxisome proliferator-activated receptor gamma | / | 0.453 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta | / | 0.452 | |
| 3dxj | NE6 | DNA-directed RNA polymerase subunit beta' | / | 0.452 | |
| 3gkj | HC3 | Niemann-Pick C1 protein | / | 0.452 | |
| 3gwn | FAD | Probable FAD-linked sulfhydryl oxidase R596 | 1.8.3.2 | 0.452 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
| 3m8c | EQU | Steroid Delta-isomerase | 5.3.3.1 | 0.452 | |
| 4at5 | MUJ | BDNF/NT-3 growth factors receptor | 2.7.10.1 | 0.452 | |
| 4gh6 | LUO | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.452 | |
| 4jlm | 1NN | Deoxycytidine kinase | 2.7.1.74 | 0.452 | |
| 4ucn | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.452 | |
| 4y8w | STR | Steroid 21-hydroxylase | / | 0.452 | |
| 2qd4 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.451 | |
| 3ffi | 3OB | Gag-Pol polyprotein | 2.7.7.49 | 0.451 | |
| 4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
| 5uvi | ZMA | Adenosine receptor A2a | / | 0.451 | |
| 1qor | NDP | Quinone oxidoreductase 1 | / | 0.450 | |
| 1u2g | APR | NAD(P) transhydrogenase subunit alpha part 1 | 1.6.1.2 | 0.450 | |
| 3bfa | 9OD | Odorant binding protein ASP1 | / | 0.450 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.450 | |
| 4em9 | TCE | Peroxisome proliferator-activated receptor gamma | / | 0.450 | |
| 1juv | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.449 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.449 | |
| 2cf6 | NAP | Cinnamyl alcohol dehydrogenase 5 | 1.1.1.195 | 0.449 | |
| 3mg3 | ECH | Orange carotenoid-binding protein | / | 0.449 | |
| 4ase | AV9 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.449 | |
| 4do3 | 0LA | Fatty-acid amide hydrolase 1 | 3.5.1.99 | 0.449 | |
| 1xzq | FON | tRNA modification GTPase MnmE | 3.6.5 | 0.448 | |
| 3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3kq7 | KQ7 | Mitogen-activated protein kinase 14 | / | 0.448 | |
| 3zcw | 4A2 | Kinesin-like protein KIF11 | / | 0.448 | |
| 4iah | 1DX | Alr2278 protein | / | 0.448 | |
| 4j6d | TES | Cytochrome P450 monooxygenase | / | 0.448 | |
| 4zm6 | ACO | N-acetyl-beta-D glucosaminidase | / | 0.448 | |
| 5iub | CLR | Adenosine receptor A2a | / | 0.448 | |
| 1hih | C20 | Gag-Pol polyprotein | / | 0.447 | |
| 1xp6 | AIU | Estrogen receptor | / | 0.447 | |
| 2qo6 | CHD | Fatty acid-binding protein 10-A, liver basic | / | 0.447 | |
| 3nbp | JGZ | Gag-Pol polyprotein | 2.7.7.49 | 0.447 | |
| 4bft | ZVT | Pantothenate kinase | 2.7.1.33 | 0.447 | |
| 4kwi | 1TJ | Reductase homolog | / | 0.447 | |
| 4nc3 | ERM | 5-hydroxytryptamine receptor 2B | / | 0.447 | |
| 4nfh | PFB | Alcohol dehydrogenase E chain | 1.1.1.1 | 0.447 | |
| 1cx2 | S58 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.446 | |
| 1e94 | ANP | ATP-dependent protease ATPase subunit HslU | / | 0.446 | |
| 1n83 | CLR | Nuclear receptor ROR-alpha | / | 0.446 | |
| 1wbw | LI4 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 2qd3 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.446 | |
| 2yix | YIX | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 4bfv | ZVV | Pantothenate kinase | 2.7.1.33 | 0.446 | |
| 4c2j | COA | 3-ketoacyl-CoA thiolase, mitochondrial | 2.3.1.16 | 0.446 | |
| 4iae | 1DX | Alr2278 protein | / | 0.446 | |
| 1i7i | AZ2 | Peroxisome proliferator-activated receptor gamma | / | 0.445 | |
| 1ot7 | CHC | Bile acid receptor | / | 0.445 | |
| 2jdv | L20 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.445 | |
| 2jg7 | NAD | Antiquitin | / | 0.445 | |
| 2vv9 | IM9 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
| 2znn | S44 | Peroxisome proliferator-activated receptor alpha | / | 0.445 | |
| 3cbs | R12 | Cellular retinoic acid-binding protein 2 | / | 0.445 | |
| 3dhe | AND | Estradiol 17-beta-dehydrogenase 1 | 1.1.1.62 | 0.445 | |
| 3hv5 | R24 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 3uwl | FOZ | Thymidylate synthase | / | 0.445 | |
| 4bgi | I4I | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.445 | |
| 4y9x | UPG | Glucosyl-3-phosphoglycerate synthase | 2.4.1.266 | 0.445 | |
| 1ezv | SMA | Cytochrome b | / | 0.444 | |
| 1rdt | L79 | Retinoic acid receptor RXR-alpha | / | 0.444 | |
| 1rrm | APR | Lactaldehyde reductase | 1.1.1.77 | 0.444 | |
| 2qjy | SMA | Cytochrome b | / | 0.444 | |
| 3dmt | NAD | Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 1.2.1.12 | 0.444 | |
| 3gki | CLR | Niemann-Pick C1 protein | / | 0.444 | |
| 3gyi | FAD | Cholesterol oxidase | 1.1.3.6 | 0.444 | |
| 3l9m | L9M | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.444 | |
| 3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.444 | |
| 3p6n | DSO | Camphor 5-monooxygenase | 1.14.15.1 | 0.444 | |
| 4af3 | VX6 | Aurora kinase B | 2.7.11.1 | 0.444 | |
| 1b8s | FAD | Cholesterol oxidase | 1.1.3.6 | 0.443 | |
| 2nmt | NHM | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.443 | |
| 3kjs | NAP | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.443 | |
| 3l6j | Z90 | Alr2278 protein | / | 0.443 | |
| 3mqe | 416 | Prostaglandin G/H synthase 2 | 1.14.99.1 | 0.443 | |
| 4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.443 | |
| 4mv8 | ACP | Biotin carboxylase | 6.3.4.14 | 0.443 | |
| 4o2z | 046 | Mitogen-activated protein kinase | / | 0.443 | |
| 1mxt | FAE | Cholesterol oxidase | 1.1.3.6 | 0.442 | |
| 1o8c | NDP | Probable acrylyl-CoA reductase AcuI | 1.3.1.84 | 0.442 | |
| 1tj0 | FAD | Bifunctional protein PutA | 1.5.5.2 | 0.442 | |
| 2b03 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.442 | |
| 2dqs | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.442 | |
| 2ibz | SMA | Cytochrome b | / | 0.442 | |
| 2z7h | GG3 | Geranylgeranyl pyrophosphate synthase | / | 0.442 | |
| 3amb | VX6 | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
| 3mfr | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.442 | |
| 4agw | NG7 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.442 | |
| 4cav | MYA | Glycylpeptide N-tetradecanoyltransferase | 2.3.1.97 | 0.442 | |
| 4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.442 | |
| 4ksp | 1SU | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.442 | |
| 4m8h | R4M | Retinoic acid receptor RXR-alpha | / | 0.442 | |
| 5a28 | MYA | Glycylpeptide N-tetradecanoyltransferase | / | 0.442 | |
| 1cbs | REA | Cellular retinoic acid-binding protein 2 | / | 0.441 | |
| 1g49 | 111 | Stromelysin-1 | 3.4.24.17 | 0.441 | |
| 1kce | CB3 | Thymidylate synthase | / | 0.441 | |
| 1kyo | SMA | Cytochrome b | / | 0.441 | |
| 1tdu | CB3 | Thymidylate synthase | / | 0.441 | |
| 1y0s | 331 | Peroxisome proliferator-activated receptor delta | / | 0.441 | |
| 2y37 | A54 | Nitric oxide synthase, inducible | 1.14.13.39 | 0.441 | |
| 2zjm | F1M | Beta-secretase 1 | 3.4.23.46 | 0.441 | |
| 3dyn | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
| 3dyq | PCG | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.441 | |
| 3otq | MZL | Bifunctional epoxide hydrolase 2 | 3.3.2.10 | 0.441 | |
| 4bfp | SWY | Tankyrase-2 | 2.4.2.30 | 0.441 | |
| 4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.441 | |
| 4m8e | 29V | Retinoic acid receptor RXR-alpha | / | 0.441 | |
| 4xxg | FAD | Cholesterol oxidase | 1.1.3.6 | 0.441 | |
| 3sn6 | P0G | Beta-2 adrenergic receptor | / | 0.441 | |
| 3rey | XAC | Adenosine receptor A2a | / | 0.441 | |
| 1e1l | FAD | NADPH:adrenodoxin oxidoreductase, mitochondrial | 1.18.1.6 | 0.440 | |
| 1h35 | R01 | Squalene--hopene cyclase | 4.2.1.129 | 0.440 | |
| 1kb9 | SMA | Cytochrome b | / | 0.440 | |
| 1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.440 | |
| 2b01 | TUD | Phospholipase A2, major isoenzyme | 3.1.1.4 | 0.440 | |
| 2ekp | NAD | 2-deoxy-D-gluconate 3-dehydrogenase | / | 0.440 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.440 | |
| 3ghv | GHC | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
| 3hdm | MMG | Serine/threonine-protein kinase Sgk1 | 2.7.11.1 | 0.440 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.440 | |
| 3lu6 | IMX | Serum albumin | / | 0.440 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.440 | |
| 4b67 | FAD | L-ornithine N(5)-monooxygenase | / | 0.440 | |
| 4dym | IYZ | Activin receptor type-1 | 2.7.11.30 | 0.440 | |
| 4fhf | 0TT | Spore photoproduct lyase | / | 0.440 | |
| 4gxs | 0YS | Glutamate receptor 2 | / | 0.440 | |
| 5iu4 | ZMA | Adenosine receptor A2a | / | 0.440 |